CytoTronics
PrivateLast Round
Seed
Sep 5, 2024
Total Funding Raised
$22.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CytoTronics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in September 2024.
CytoTronics is a biotechnology company that develops semiconductor-based systems for studying cell biology, enabling researchers to visualize live cell function at scale and obtain real-time data on cell behavior to explore complex biological processes in greater detail.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Semiconductors, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoTronics Comparables
Compare CytoTronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3Brain AG | 83% | |
| MaxWell Biosystems | 81% | |
| Axion BioSystems | 80% |
For institutional investors. Book with your work email.
CytoTronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2024 | ||||
| Seed | Apr 28, 2022 |
For institutional investors. Book with your work email.
CytoTronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Seed |
| LYFE Capital | Seed |
| BoxOne Ventures | Seed |
| Anzu Partners | Seed |
| Draper Associates | Seed |
| RIT Venture Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 54% MoM.
- Jun 22, 2026
Monthly visitors grew 181% MoM, reaching 3.2K.
For institutional investors. Book with your work email.
CytoTronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CytoTronics's valuation, stock price, and market status.
Is CytoTronics a public or private company?
CytoTronics is a private company.
What is the current stock price of CytoTronics?
CytoTronics is a private company, so its shares have no public market price. Caplight tracks CytoTronics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CytoTronics worth (valuation)?
Valuation information for CytoTronics is not publicly available.
Can I buy CytoTronics stock?
CytoTronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CytoTronics's last funding round?
CytoTronics's most recent funding round was Seed on September 5, 2024.
Who are the main investors in CytoTronics?
Key investors in CytoTronics include LYFE Capital, Anzu Partners.
Will CytoTronics IPO soon?
No public IPO plans have been announced for CytoTronics.
How can I track CytoTronics secondary market activity?
Caplight tracks bids, offers, and trades in CytoTronics's shares on secondary markets.